L-Aspartic aicd sodium
| Code | Size | Price |
|---|
| TAR-T19554-500mg | 500mg | £103.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
L-Aspartic aicd sodium is an amino acid.
CAS:
3792-50-5
Formula:
C4H8NNaO4
Molecular Weight:
157.101
Pathway:
Membrane transporter/Ion channel|Metabolism|Others
Purity:
0.98
SMILES:
[NaH].N[C@@H](CC(O)=O)C(O)=O
Target:
Sodium Channel|Endogenous Metabolite|Others
References
1. Leopold CS, et al. In vivo pharmacokinetic study for the assessment of poly(L-aspartic acid) as a drug carrier for colon-specific drug delivery. J Pharmacokinet Biopharm. 1995 Aug;23(4):397-406.
2. Hosoya K, et al. Blood-brain barrier produces significant efflux of L-aspartic acid but not D-aspartic acid: in vivo evidence using the brain efflux index method. J Neurochem. 1999 Sep;73(3):1206-11.